BioCentury | Oct 26, 2015
Strategy

Collaborating on combos

...TDO ; TDO2 ) inhibitors from Curadev Pharma Pvt. Ltd. , including lead compound CRD1152...
...Preclin Not started Areva Med LLC Lead-212 Radio-immunotherapy Preclin Not started Curadev Pharma Pvt. Ltd. CRD1152...
BioCentury | Apr 27, 2015
Company News

Curadev, Roche deal

...cancer. The deal gives Roche exclusive, worldwide rights to develop and commercialize Curadev’s lead compound, CRD1152...
...double digits. Roche declined to say when it plans to start a clinical trial of CRD1152...
BioCentury | Apr 21, 2015
Company News

Curadev, Roche partner to develop IDO1/TDO inhibitors for cancer

...cancer. The deal gives Roche exclusive, worldwide rights to develop and commercialize Curadev's lead compound, CRD1152...
...double digits. Roche declined to say when it plans to start a clinical trial of CRD1152...
Items per page:
1 - 3 of 3